Mark F. McLaughlin

657 total citations
13 papers, 356 citations indexed

About

Mark F. McLaughlin is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Mark F. McLaughlin has authored 13 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Molecular Biology. Recurrent topics in Mark F. McLaughlin's work include Radiopharmaceutical Chemistry and Applications (6 papers), Renal cell carcinoma treatment (3 papers) and Radiation Therapy and Dosimetry (3 papers). Mark F. McLaughlin is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Renal cell carcinoma treatment (3 papers) and Radiation Therapy and Dosimetry (3 papers). Mark F. McLaughlin collaborates with scholars based in United States, Australia and Italy. Mark F. McLaughlin's co-authors include Saed Mirzadeh, Stephen J. Kennel, Jonathan S. Wall, R. A. Boll, Adam J. Rondinone, J. David Robertson, Jonathan Woodward, Dorit Donoviel, Jeffrey A. Jones and Sashi Debnath and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and European Urology.

In The Last Decade

Mark F. McLaughlin

12 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark F. McLaughlin United States	10	185	174	57	45	43	13	356
M. Neves Portugal	9	212 1.1×	85 0.5×	35 0.6×	63 1.4×	68 1.6×	21	334
Laurence Morandeau Australia	11	222 1.2×	128 0.7×	47 0.8×	68 1.5×	21 0.5×	28	342
K.V. Vimalnath India	13	283 1.5×	118 0.7×	19 0.3×	54 1.2×	65 1.5×	45	437
Michael S. Kovacs Canada	12	361 2.0×	166 1.0×	79 1.4×	32 0.7×	58 1.3×	39	604
C. Cutler United States	12	308 1.7×	139 0.8×	33 0.6×	58 1.3×	76 1.8×	20	476
Y. Sheh United States	4	340 1.8×	142 0.8×	41 0.7×	93 2.1×	19 0.4×	7	393
Thomas Buettner Germany	12	202 1.1×	124 0.7×	60 1.1×	89 2.0×	48 1.1×	13	462
Shota Konishi Japan	13	272 1.5×	154 0.9×	76 1.3×	86 1.9×	28 0.7×	25	561
Mai Lin United States	14	307 1.7×	112 0.6×	69 1.2×	108 2.4×	55 1.3×	24	437
Micòl Pasquali Italy	15	296 1.6×	100 0.6×	22 0.4×	62 1.4×	43 1.0×	23	421

Countries citing papers authored by Mark F. McLaughlin

Since Specialization

Citations

This map shows the geographic impact of Mark F. McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark F. McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark F. McLaughlin more than expected).

Fields of papers citing papers by Mark F. McLaughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark F. McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark F. McLaughlin. The network helps show where Mark F. McLaughlin may publish in the future.

Co-authorship network of co-authors of Mark F. McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark F. McLaughlin. A scholar is included among the top collaborators of Mark F. McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark F. McLaughlin. Mark F. McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Hannan, Raquibul, Mark F. McLaughlin, Laurentiu M. Pop, et al.. (2023). Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer. European Urology. 84(3). 275–286. 27 indexed citations

Debnath, Sashi, Ning Zhou, Mark F. McLaughlin, et al.. (2022). PSMA-Targeting Imaging and Theranostic Agents—Current Status and Future Perspective. International Journal of Molecular Sciences. 23(3). 1158–1158. 54 indexed citations

Freifeld, Yuval, Iván Pedrosa, Mark F. McLaughlin, et al.. (2022). Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus. Urologic Oncology Seminars and Original Investigations. 40(4). 166.e9–166.e13. 18 indexed citations

Howard, Jeffrey, Mark F. McLaughlin, Xiaosong Meng, et al.. (2021). Metastasis-directed radiation therapy after radical cystectomy for bladder cancer. Urologic Oncology Seminars and Original Investigations. 39(11). 790.e1–790.e7. 12 indexed citations

McLaughlin, Mark F., Michael R. Folkert, Robert Timmerman, et al.. (2021). Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation Therapy. Advances in Radiation Oncology. 6(4). 100713–100713. 24 indexed citations

McLaughlin, Mark F., et al.. (2020). Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer. PLoS ONE. 15(11). e0241505–e0241505. 8 indexed citations

McLaughlin, Mark F., Dorit Donoviel, & Jeffrey A. Jones. (2017). Novel Indications for Commonly Used Medications as Radiation Protectants in Spaceflight. Aerospace Medicine and Human Performance. 88(7). 665–676. 30 indexed citations

McLaughlin, Mark F., David J. Robertson, Paul H. Pevsner, et al.. (2013). LnPO ₄ Nanoparticles Doped with Ac-225 and Sequestered Daughters for Targeted Alpha Therapy. Cancer Biotherapy and Radiopharmaceuticals. 29(1). 34–41. 38 indexed citations

McLaughlin, Mark F., Jonathan Woodward, R. A. Boll, et al.. (2013). Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy. PLoS ONE. 8(1). e54531–e54531. 95 indexed citations

10.

McLaughlin, Mark F., et al.. (2013). Gold-coated lanthanide phosphate nanoparticles for an ²²⁵Ac in vivo alpha generator. Radiochimica Acta. 101(9). 595–600. 25 indexed citations

11.

Cutler, Cathy S., Nripen Chanda, Ravi Shukla, et al.. (2012). Nanoparticles and Phage Display Selected Peptides for Imaging and Therapy of Cancer. Recent results in cancer research. 194. 133–147. 16 indexed citations

12.

Kondziolka, Douglas, Yoshimasa Mori, A. Julio Martínez, et al.. (1998). Beneficial Effects of the Radio protectant 21-Aminosteroid U-74389G in a Radiosurgery Rat Malignant Glioma Model. Neurosurgery. 43(3). 678–678.

13.

McLaughlin, Mark F., et al.. (1964). Thermal Decompostition and Applications of n-Butyl-4,4-bis(tert-butylperoxy)valerate. I&EC Product Research and Development. 3(4). 261–264. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact